- ►ahajournals.org PM Ridker, PWF Wilson, SM Grundy - Circulation, 2004 - Am Heart Assoc Of novel risk factors for cardiovascular disease currently under investigation, high-sensitivity
C-reactive protein (hsCRP) is the most promising. To date, more than 20 prospective epidemiologic
studies have demonstrated that ... Cited by 367 - Related articles - All 8 versions
K Chen, F Li, J Li, H Cai, S Strom, A Bisello, DE … - Nature …, 2006 - webpages.uah.edu The mechanisms underlying leptin resistance are still being defined. We report here the presence in
human blood of several serum leptin-interacting proteins (SLIPs), isolated by leptin-affinity
chromatography and identified by ... Cited by 101 - Related articles - BL Direct - All 7 versions
E Bonora - Annals of medicine, 2006 - informahealthcare.com The metabolic syndrome, which is very common in the general population, is defined by the clustering
of several classic cardiovascular risk factors, such as type 2 diabetes, hypertension, high
triglycerides and low ... Cited by 60 - Related articles - BL Direct - All 11 versions
- ►onlinejacc.org DV Anand, A Lahiri, E Lim, D Hopkins, R Corder - Journal of the American …, 2006 - Elsevier This study sought to prospectively evaluate the relationship between plasma osteoprotegerin (OPG),
inflammatory biomarkers (high-sensitivity C-reactive protein [hs-CRP], interleukin-6 [IL-6],
coronary artery calcification ... Cited by 53 - Related articles - BL Direct - All 7 versions
L Qi, RM van Dam, S Liu, M Franz, C Mantzoros, FB … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—After adjustment for age, BMI, lifestyle, and dietary covariates, intakes of whole grains
and bran were both associated with significantly decreasing trends of C-reactive protein (CRP) (P
for trend = 0.03 and 0.007, ... Cited by 49 - Related articles - BL Direct - All 6 versions
DJ Stocker, AJ Taylor, RW Langley, MR Jezior, RA … - American heart journal, 2007 - Elsevier Metformin and rosiglitazone treatment led to similar significant improvements in glycemic control
(HbA 1c −1.08% in the rosiglitazone group and −1.18% in the metformin group, P =
nonsignificant). High-sensitivity C- ... Cited by 48 - Related articles - All 9 versions
MPM de Maat, A Trion - Current opinion in lipidology, 2004 - journals.lww.com Purpose of review C-reactive protein (CRP) is consistently associated with cardiovascular disease in
prospective and cross-sectional clinical and epidemiological studies. Inflammation is an important
mechanism in cardiovascular ... Cited by 45 - Related articles - All 6 versions
GI Varughese, J Tomson, GYH Lip - International Journal of …, 2005 - interscience.wiley.com Diabetes mellitus is a disease, which is at the epitome of cardiovascular risk factors causing
considerable morbidity and mortality. In addition to microvascular complications, there is two- to
six-fold increased risk of ... Cited by 41 - Related articles - All 4 versions
PD Home, NP Jones, SJ Pocock, H Beck- … - Diabetic …, 2007 - pubmedcentral.nih.gov RECORD, a multicentre, parallel-group study of cardiovascular outcomes, enrolled people with an HbA
1c of 7.1–9.0% on maximum doses of metformin or sulphonylurea. If on metformin they were
randomized to add-on rosiglitazone ... Cited by 41 - Related articles - BL Direct - All 8 versions
M Soinio, J Marniemi, M Laakso, S Lehto, T … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Altogether, 157 patients died from CHD and 254 had a nonfatal or fatal CHD event. Patients
with hs-CRP >3 mg/l had a higher risk for CHD death than patients with hs-CRP ≤3 mg/l (19.8 and
12.9%, respectively, P = 0.004). In ... Cited by 34 - Related articles - BL Direct - All 5 versions
